Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 1;113(5):1054-1062.
doi: 10.1016/j.ijrobp.2022.04.035. Epub 2022 May 2.

Unilateral Radiation Therapy for Tonsillar Cancer: Treatment Outcomes in the Era of Human Papillomavirus, Positron-Emission Tomography, and Intensity Modulated Radiation Therapy

Nicolette Taku  1 , Gregory Chronowski  1 , G Brandon Gunn  1 , William H Morrison  1 , Neil D Gross  2 , Amy C Moreno  1 , Renata Ferrarotto  3 , Steven J Frank  1 , C David Fuller  1 , Ryan P Goepfert  2 , Jack Phan  1 , Stephen Y Lai  2 , Jay P Reddy  1 , David I Rosenthal  1 , Adam S Garden  4
Affiliations

Unilateral Radiation Therapy for Tonsillar Cancer: Treatment Outcomes in the Era of Human Papillomavirus, Positron-Emission Tomography, and Intensity Modulated Radiation Therapy

Nicolette Taku et al. Int J Radiat Oncol Biol Phys. .

Abstract

Purpose: The goal of this study was to evaluate disease, survival, and toxic effects after unilateral radiation therapy treatment for tonsillar cancer.

Methods and materials: A retrospective study was performed of patients treated at our institution within the period from 2000 to 2018. Summary statistics were used to assess the cohort by patient characteristics and treatments delivered. The Kaplan-Meier method was used to determine survival outcomes.

Results: The cohort comprised 403 patients, including 343 (85%) with clinical and/or radiographic evidence of ipsilateral cervical nodal disease and 181 (45%) with multiple involved nodes. Human papillomavirus was detected in 294 (73%) tumors. Median follow-up time was 5.8 years. Disease relapse was infrequent with local recurrence in 9 (2%) patients, neck recurrence in 13 (3%) patients, and recurrence in the unirradiated contralateral neck in 9 (2%) patients. Five- and 10-year overall survival rates were 94% and 89%, respectively. Gastrostomy tubes were needed in 32 (9%) patients, and no patient had a feeding tube 6 months after therapy.

Conclusions: For patients with well-lateralized tonsillar tumors and no clinically evident adenopathy of the contralateral neck, unilateral radiation therapy offers favorable rates of disease outcomes and a relatively low toxicity profile.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Overall survival in 403 patients treated with unilateral radiation for cancer of the tonsil.
Fig. 2.
Fig. 2.
Progression-free survival in 403 patients treated with unilateral radiation for cancer of the tonsil.
See this image and copyright information in PMC

References

    1. Fletcher GH, Lindberg RD. Squamous cell carcinomas of the tonsillar area and palatine arch. AJR Am J Roentgenol 1966;96:574–587. - PubMed
    1. Berger DS, Fletcher GH, Lindberg RD, Jesse RH Jr. Elective irradiation of the neck lymphatics for squamous cell carcinomas of the nasopharynx and oropharynx. Am J Roentgenol Radium Ther Nucl Med 1971;111:66–72. - PubMed
    1. Al-Mamgani A, van Werkhoven E, Navran A, et al. Contralateral regional recurrence after elective unilateral neck irradiation in oropharyngeal carcinoma: A literature-based critical review. Cancer Treat Rev 2017;59:102–108. - PubMed
    1. Deschuymer S, Mehanna H, Nuyts S. Toxicity reduction in the treatment of HPV positive oropharyngeal cancer: Emerging combined modality approaches. Front Oncol 2018;8:439. - PMC - PubMed
    1. Taku N, Wang L, Garden AS, et al. Proton therapy for HPV-associated oropharyngeal cancers of the head and neck: A de-intensification strategy. Curr Treat Options Oncol 2021;22:54. - PMC - PubMed

Publication types

MeSH terms